These are Morgan Stanley's top stocks to own for the next year.
From e-commerce firm Amazon to pharmaceutical giant Eli Lilly , Morgan Stanley's top stocks to own for the next 12 months spans a wide array of sectors. The firm compiled its "Vintage Values" picks for 2025 in a Wednesday note, which encompasses "mid- to large-caps likely to realize superior risk-adjusted returns over the next year." The majority of Morgan Stanley's picks are tilted toward growth, with 67% of the picks meeting that classification.
mountain Amazon stock. "Advertising serves as a key area for both further growth potential and profitability flow-through," he added. Eli Lilly also made the list. Shares of the Alzheimer's and diabetes drug maker have surged 60% in 2024. Analyst Terence Flynn's $1,106 price target forecasts 18% upside for Eli Lilly's shares. LLY YTD mountain Eli Lilly stock.
Eli Lilly And Co Amazon.Com Inc Markets Investment Strategy Business News
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Morgan Stanley says this is a 'highly attractive' stock with long growth historyMorgan Stanley says this is a 'highly attractive' stock with long growth history
Read more »
Morgan Stanley thinks this stock's “goldilocks” potential is in the rearviewMorgan Stanley thinks this stock's “goldilocks” potential is in the rearview
Read more »
This stock is one of Morgan Stanley's top Retail Overweight callsThis stock is one of Morgan Stanley's top Retail Overweight calls
Read more »
Morgan Stanley sees a 'favorable entry ahead of multiple catalysts' in this software stockMorgan Stanley sees a 'favorable entry ahead of multiple catalysts' in this software stock
Read more »
How investors could net a 60% return from this oil stock, according to Morgan StanleyThe Wall Street investment bank upgraded the Brazilian oil and gas producer to overweight.
Read more »
Morgan Stanley added this stock to its APxJ and GEM Focus Lists, giving it 40% upsideMorgan Stanley added this stock to its APxJ and GEM Focus Lists, giving it 40% upside
Read more »